Dharmesh Gopalakrishnan
Impact in
-
- Cancer Genomics and Diagnostics
-
- Cancer Immunotherapy and Biomarkers
Papers in
- Surgery 14
- Bladder and Urothelial Cancer Treatments 12
- Urinary and Genital Oncology Studies 6
-
- Prostate Cancer Treatment and Research 5
- Renal cell carcinoma treatment 3
- Co-authors
- Petros Grivas (7 shared papers)Moshe Chaim Ornstein (5 shared papers)Vadim S. Koshkin (4 shared papers)Athanasios Papatsoris (1 shared paper)Sunil Dogra (1 shared paper)Aman Sharma (1 shared paper)Rajesh Vijayvergiya (1 shared paper)Malav P. Parikh (1 shared paper)
- Journals
- Journal of Clinical Oncology (14 papers)Frontiers in Oncology (2 papers)JNCI Journal of the National Cancer Institute (1 paper)Therapeutics and Clinical Risk Management (1 paper)Cancer Chemotherapy and Pharmacology (1 paper)
- Partner nations
- United StatesCanadaChina
In The Last Decade
Dharmesh Gopalakrishnan
22 papers receiving 198 citations
Peers
Comparison fields: 5 of 40
- Cancer Research 49
- Oncology 68
- Surgery 91
- Hepatology 13
- Immunology 34
Countries citing papers authored by Dharmesh Gopalakrishnan
This map shows the geographic impact of Dharmesh Gopalakrishnan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dharmesh Gopalakrishnan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dharmesh Gopalakrishnan more than expected).
Fields of papers citing papers by Dharmesh Gopalakrishnan
This network shows the impact of papers produced by Dharmesh Gopalakrishnan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dharmesh Gopalakrishnan. The network helps show where Dharmesh Gopalakrishnan may publish in the future.
Co-authors
The 25 scholars most cited alongside Dharmesh Gopalakrishnan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 46 | |
| 2 | 2019 | 31 | |
| 3 | 2013 | 24 | |
| 4 | 2019 | 21 | |
| 5 | 2018 | 19 | |
| 6 | 2018 | 17 | |
| 7 | 2021 | 11 | |
| 8 | 2017 | 5 | |
| 9 | 2023 | 4 | |
| 10 | 2023 | 3 | |
| 11 | 2017 | 3 | |
| 12 | 2021 | 2 | |
| 13 | 2017 | 2 | |
| 14 | 2021 | 2 | |
| 15 | 2023 | 1 | |
| 16 | 2024 | 1 | |
| 17 | 2020 | 1 | |
| 18 | 2018 | 1 | |
| 19 | 2015 | 1 | |
| 20 | 2023 | 1 |
About Dharmesh Gopalakrishnan
Dharmesh Gopalakrishnan is a scholar working on Surgery, Pulmonary and Respiratory Medicine, Oncology, Epidemiology and Radiology, Nuclear Medicine and Imaging, having authored 29 papers that have together received 198 indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (12 papers), Urinary and Genital Oncology Studies (6 papers), Cancer Immunotherapy and Biomarkers (5 papers), Prostate Cancer Treatment and Research (5 papers), Radiopharmaceutical Chemistry and Applications (4 papers), Renal cell carcinoma treatment (3 papers), Cancer Genomics and Diagnostics (3 papers) and Hepatocellular Carcinoma Treatment and Prognosis (2 papers). The work is most often cited by research in Cancer Research (49 citations), Oncology (68 citations), Surgery (91 citations), Hepatology (13 citations) and Immunology (34 citations). Dharmesh Gopalakrishnan has collaborated with scholars based in United States, Canada and China. Frequent co-authors include Petros Grivas, Moshe Chaim Ornstein, Vadim S. Koshkin, Athanasios Papatsoris, Sunil Dogra, Aman Sharma, Rajesh Vijayvergiya, Malav P. Parikh, Pedro C. Barata and Gursimran Kochhar. Their work appears in journals such as Journal of Clinical Oncology, Frontiers in Oncology, JNCI Journal of the National Cancer Institute, Therapeutics and Clinical Risk Management and Cancer Chemotherapy and Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.